These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6230579

  • 1. [Random sample control of the effectiveness of preventive rubella vaccination].
    Happe E.
    Offentl Gesundheitswes; 1984 Feb; 46(2):96. PubMed ID: 6230579
    [No Abstract] [Full Text] [Related]

  • 2. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    Kańtoch M, Rudnicka H, Imbs D.
    Przegl Epidemiol; 1985 Feb; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract] [Full Text] [Related]

  • 3. Rubella prevention in family practice with RA27/3 vaccine.
    Hansen NH.
    J Fam Pract; 1980 Oct; 11(4):537-42. PubMed ID: 7420029
    [Abstract] [Full Text] [Related]

  • 4. [Comparative studies of immunogenicity and reactogenicity of various rubella vaccines. II. Seroconversion and post-vaccination reactions in girls immunized against rubella with Rudivax and Cendevax vaccines].
    Imbs D, Kańtoch M, Rudnicka H, Niedźwiedzka-Adamaszek E, Pychyńska A, Zegadło W, Stempień R, Słowińska I, Kretkowska A.
    Przegl Epidemiol; 1987 Oct; 41(2):141-8. PubMed ID: 3423282
    [No Abstract] [Full Text] [Related]

  • 5. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rubella vaccination related to immunological status.
    Morrison A, Whitmore M, Edmond E.
    Health Bull (Edinb); 1977 Jul; 35(4):192-6. PubMed ID: 903223
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR, Schneider F, Muller CP.
    Vaccine; 2006 Mar 24; 24(14):2594-601. PubMed ID: 16427163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Vaccination against viral infections in children: what are the risks for young adults?].
    del Giudice P, Hubiche T.
    Ann Dermatol Venereol; 2011 Feb 24; 138(2):83-4. PubMed ID: 21333815
    [No Abstract] [Full Text] [Related]

  • 19. Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.
    Cohen D, Muhsen Kh, Aboudy Y, Harari H, Mendelson E, Green MS.
    Vaccine; 2006 Jul 07; 24(27-28):5604-8. PubMed ID: 16716460
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.